The Enterprise Value as of September 2024 (TTM) for Absci Corporation (ABSI) is 391.08M

According to Absci Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 391.08M. This represents a change of 32.97% compared to the average of 294.11M of the last 4 quarters.

Absci Corporation (ABSI) Historical Enterprise Value (quarterly & annually)

How has ABSI Enterprise Value performed in the past?

The mean historical Enterprise Value of Absci Corporation over the last ten years is 983.16M. The current 391.08M Enterprise Value has changed 3.88% with respect to the historical average. Over the past ten years (40 quarters), ABSI's Enterprise Value was at its highest in in the June 2021 quarter at 2.02B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Absci Corporation (ABSI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Absci Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Absci Corporation (ABSI) Average Enterprise Value

How has ABSI Enterprise Value performed in the past?

The current Enterprise Value of Absci Corporation (ABSI) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Absci Corporation (ABSI) Enterprise Value vs. Peers

How is ABSI’s Enterprise Value compared to its peers?

Absci Corporation’s Enterprise Value is less than Recursion Pharmaceuticals, Inc. (1.42B), greater than Affimed N.V. (57.84M), less than Sana Biotechnology, Inc. (941.95M), less than Relay Therapeutics, Inc. (1.24B), greater than Exscientia plc (369.76M), less than VectivBio Holding AG (848.58M), greater than Zura Bio Limited (41.78M), greater than Elevation Oncology, Inc. (8.23M), less than Icosavax, Inc. (713.87M), greater than AVROBIO, Inc. (-85302404.00), greater than Hepion Pharmaceuticals, Inc. (2.10M), greater than Precision BioSciences, Inc. (-17676582.00), greater than Caribou Biosciences, Inc. (171.09M), greater than ContraFect Corporation (-1135867.00), greater than Graphite Bio, Inc. (-15007658.00), less than Day One Biopharmaceuticals, Inc. (968.16M), greater than Acumen Pharmaceuticals, Inc. (113.46M), greater than X4 Pharmaceuticals, Inc. (51.07M), less than Inozyme Pharma, Inc. (406.00M),

Build a custom stock screener for Absci Corporation (ABSI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Absci Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Absci Corporation (ABSI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Absci Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.